CACNA1G Protein - Cav3.1 T-type Calcium Channel

📖 Wiki Page

protein1354 wordssynced 2026-04-02

CACNA1G Protein (Cav3.1 T-type Calcium Channel)

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Cav3.1 (T-type Calcium Channel Alpha-1G)</th></tr>
<tr><td>Protein Name</td><td>T-type Calcium Channel Alpha-1G</td></tr>
<tr><td>Gene</td><td><a href="/genes/cacna1g">CACNA1G</a></td></tr>
<tr><td>UniProt ID</td><td><a href="https://www.uniprot.org/uniprot/O43497" target="_blank">O43497</a></td></tr>
<tr><td>Ion Channel Family</td><td>Voltage-gated calcium channel (Cav3)</td></tr>
<tr><td>Molecular Weight</td><td>262 kDa</td></tr>
<tr><td>Subcellular Localization</td><td>Cell membrane (neuronal dendrites and soma)</td></tr>
<tr><td>Protein Structure</td><td>24 transmembrane segments, 4 domains</td></tr>
<tr><td>Channel Type</td><td>Low-voltage-activated (LVA)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">Alzheimer's Disease</a>, <a href="/wiki/sca42nd" style="color:#ef9a9a">SCA42ND</a>, <a href="/wiki/absence-seizures" style="color:#ef9a9a">absence seizures</a>, <a href="/wiki/intellectual-disability" style="color:#ef9a9a">intellectual disability</a>, <a href="/wiki/neurodegeneration" style="color:#ef9a9a">neurodegeneration</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-8d270062" style="co

...

CACNA1G Protein (Cav3.1 T-type Calcium Channel)

Overview

CACNA1G encodes the alpha-1G subunit of low-voltage-activated (LVA) T-type calcium channels, commonly known as Cav3.1. T-type calcium channels are unique among voltage-gated calcium channels in their ability to activate at relatively negative membrane potentials, making them crucial for neuronal pacemaking, burst firing, and thalamic oscillations[@perezreyes2003]. Cav3.1 is the principal T-type channel isoform in the thalamus and is widely expressed throughout the central nervous system, where it plays essential roles in sleep-wake cycles, sensory processing, and neuronal excitability regulation.

Dysregulation of Cav3.1 channel function has been implicated in multiple neurological disorders, including epilepsy, migraine, and neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD)[@Sheng2022]. The channel's unique gating properties—rapid activation and inactivation, and the ability to generate rebound low-threshold calcium spikes—make it a critical player in both normal neuronal function and pathological states.

Molecular Structure and Gating

Channel Architecture

Cav3.1 is a member of the voltage-gated calcium channel superfamily and shares the general architecture of these proteins[@catterall2000]:

Alpha-1 Subunit Structure:

Four Homologous Domains (I-IV): Each domain contains six transmembrane segments (S1-S6)
Voltage Sensor (S1-S4): The S4 segment contains positively charged arginine residues that sense membrane potential changes
Pore Loop (between S5 and S6): Forms the ion selectivity filter
C-terminal Regulatory Domain: Contains sites for modulation by kinases, neurotransmitters, and second messengers

Unique Features of Cav3.1:

Different S6 segment architecture compared to high-voltage-activated (HVA) channels
Faster activation kinetics at negative potentials
Distinct inactivation mechanisms (both voltage-dependent and calcium-dependent)

Gating Properties

Cav3.1 exhibits distinctive gating characteristics[@Talavera2003]:

Low-Voltage Activation: Activation begins at approximately -70 mV, with maximal conductance near -30 mV

Rapid Activation: Channel opening occurs within 1-2 milliseconds after depolarization

Fast Inactivation: Inactivation develops within 10-50 ms, following a monoexponential time course

Window Current: A small sustained current through the overlap of activation and inactivation curves enables steady-state calcium influx at resting membrane potentials

Rebound Depolarization: After hyperpolarization, channels recover from inactivation and can generate low-threshold calcium spikes

Energetics of Gating

The energetics of Cav3.1 gating involve[@Gomora2001]:

Voltage dependence: The gating charge movement is approximately 12-14 elementary charges
Activation energy: Relatively low energy barrier for channel opening
Modulation by intracellular ions: Calcium and magnesium differentially affect channel inactivation

Normal Physiological Function

Neuronal Pacemaking

Cav3.1 channels play a critical role in spontaneous neuronal firing, particularly in thalamic neurons and certain cortical interneurons[@Dreyfus2010]:

Low-threshold calcium spikes: Depolarization from hyperpolarized states triggers T-type channel opening, generating a burst of calcium influx
Rebound firing: After inhibitory input, T-type channels drive rebound action potential generation
Rhythmic oscillations: Cav3.1 contributes to delta wave generation during sleep and spindle-wave discharges

Thalamic Oscillations

In the thalamus, Cav3.1 is essential for[@huguenard1998]:

Sleep spindles: Synchronized oscillations (7-14 Hz) characteristic of stage 2 sleep
Delta waves: Slow-wave oscillations (0.5-4 Hz) during deep sleep
Absence epilepsy: Pathological thalamocortical oscillations that manifest as spike-and-wave discharges

Sensory Processing

Cav3.1 channels contribute to sensory processing in various ways:

Retinal signaling: Involved in rod and cone pathway processing
Auditory processing: Modulates sound encoding in the inferior colliculus
Somatosensory cortex: Influences tactile sensation integration

Dendritic Integration

Cav3.1 channels on dendritic shafts enable:

Temporal summation: Facilitation of repetitive synaptic inputs
Location-specific processing: Differential integration based on synapse location
Back-propagation support: Aids in action potential propagation into dendrites

Role in Neurodegenerative Diseases

Alzheimer's Disease

Cav3.1 channel dysfunction contributes to several aspects of Alzheimer's disease pathology[@Cain2018]:

Calcium Dysregulation: AD is characterized by abnormal calcium signaling. T-type channels contribute to this through:

Increased window current at depolarized membrane potentials
Enhanced calcium influx during repetitive neuronal activity
Amplification of amyloid-beta induced calcium dysregulation

Neuronal Hyperexcitability: AD neurons often show hyperexcitability, partly due to:

Upregulation of Cav3.1 in certain neuronal populations
Reduced inactivation kinetics
Increased channel density in early disease stages

Therapeutic Implications: Modulating Cav3.1 activity may provide benefits:

T-type channel blockers reduce calcium dysregulation
Normalize neuronal firing patterns
Protect against amyloid-beta toxicity

Parkinson's Disease

In Parkinson's disease, Cav3.1 plays a complex role in basal ganglia function[@Lu2015]:

Thalamic Dysfunction: PD affects thalamic oscillations through:

Altered Cav3.1 expression in the thalamus
Disrupted sleep-wake cycles
Abnormal low-threshold spike bursts

Deep Brain Stimulation: T-type channels are implicated in the mechanisms of DBS:

Cav3.1 modulation may contribute to therapeutic effects
Frequency-dependent effects involve T-type channel gating

Dopaminergic Modulation: Dopamine modulates T-type channel function:

D2 receptor activation reduces Cav3.1 currents
Loss of dopaminergic input alters thalamic excitability

Epilepsy

Cav3.1 mutations cause or contribute to several epilepsy syndromes[@Ernst2019]:

Childhood Absence Epilepsy: Gain-of-function mutations in CACNA1G:

Increased channel conductance
Enhanced burst firing
Lower threshold for thalamic oscillations

Febrile Seizures: Temperature-sensitive mutations

Fever-induced channel dysfunction
Hyperexcitability during hyperthermia

Therapeutic Targeting: T-type channel blockers are used clinically:

Ethosuximide: Primary treatment for absence seizures
Valproic acid: Broad-spectrum anticonvulsant
Zonisamide: Newer T-type targeting agent

Migraine

Cav3.1 contributes to migraine pathophysiology:

Cortical spreading depression initiation
Thalamic pain processing
Trigeminal nucleus caudalis activation

Signaling Pathways

Modulation by Second Messengers

Cav3.1 activity is modulated by multiple intracellular signaling pathways[@Chemin2002]:

Protein Kinase C (PKC):

PKC phosphorylation reduces current amplitude
Alters voltage dependence of activation

Calmodulin:

Calcium-dependent inactivation via calmodulin
Provides feedback regulation of calcium influx

cAMP/PKA:

PKA phosphorylation increases current magnitude
Modulates channel trafficking to the membrane

Interaction with Other Ion Channels

Cav3.1 interacts with various ion channels:

HVA Calcium Channels: Cross-talk in calcium signaling
Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels: Coordinated pacemaking
Sodium channels: Co-localization in axon initial segments

Therapeutic Targeting

Clinical Applications

T-type calcium channels are therapeutic targets for[@Zamponi2020]:

Anticonvulsants:

Ethosuximide: Primary mechanism is T-type (particularly Cav3.1/3.2) blockade
Valproic Acid: Multiple mechanisms including T-type inhibition
Zonisamide: Blocks T-type currents, useful for multiple seizure types

Migraine Prevention:

Ethosuximide: Investigated for migraine prophylaxis
Migrantat: T-type modulators in development

Movement Disorders:

Zonisamide: Approved for Parkinson's disease in Japan

Drug Development

Several approaches are being explored[@Cheong2023]:

Selective T-type Blockers:

TTA-P2: Investigational selective T-type blocker
Z944: Pan-T-type inhibitor with good brain penetration
NNC 55-0396: Selective Cav3.1 antagonist

Channel Subtype Specificity:

Cav3.1-selective compounds for thalamic disorders
Cav3.2-selective agents for peripheral applications

State-Dependent Modulation:

Use-dependent blockers for pathological firing
Enhanced affinity for inactivated states

Expression Patterns

Brain Regional Distribution

Cav3.1 is expressed throughout the brain[@Zhang2013]:

Thalamus: Highest expression, particularly in relay neurons
Cerebral Cortex: Layer 2/3 and layer 5 pyramidal neurons
Cerebellum: Purkinje cells and deep cerebellar nuclei
Basal Ganglia: Substantia nigra pars reticulata, globus pallidus
Hippocampus: CA1 pyramidal cells and interneurons

Cell-Type Specificity

Neurons: Primary expression in excitatory and inhibitory neurons
Astrocytes: Low or absent expression
Oligodendrocytes: Some expression in premyelinating stages
Microglia: Not typically expressed

Mutations and Channelopathies

Disease-Causing Mutations

CACNA1G mutations are associated with several neurological conditions[@Huang2017]:

Gain-of-Function Mutations:

Childhood absence epilepsy
Febrile seizures plus
Spinocerebellar ataxia

Loss-of-Functional Mutations:

Cardiac arrhythmias (in some cases)
Neurodevelopmental disorders

Genotype-Phenotype Correlations

Specific domain mutations correlate with disease phenotype
S4 segment mutations often cause epilepsy
C-terminal mutations may cause ataxia

CACNA1G Protein - Cav3.1 T-type Calcium Channel

CACNA1G Protein (Cav3.1 T-type Calcium Channel)

CACNA1G Protein (Cav3.1 T-type Calcium Channel)

Overview

Molecular Structure and Gating

Channel Architecture

Gating Properties

Energetics of Gating

Normal Physiological Function

Neuronal Pacemaking

Thalamic Oscillations

Sensory Processing

Dendritic Integration

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Epilepsy

Migraine

Signaling Pathways

Modulation by Second Messengers

Interaction with Other Ion Channels

Therapeutic Targeting

Clinical Applications

Drug Development

Expression Patterns

Brain Regional Distribution

Cell-Type Specificity

Mutations and Channelopathies

Disease-Causing Mutations

Genotype-Phenotype Correlations

See Also